AVALON GLOBOCARE CORP (AVCO) Stock News

USA - NASDAQ:AVCO - US05344R1041 - Common Stock

0.5259 USD

-0.1 (-16.52%)

Last: 11/9/2022, 8:00:00 PM

0.601 USD

+0.08 (+14.28%)

After Hours: 11/9/2022, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AVCO Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Avalon GloboCare Corp. - Mentions: ALBT

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”

3 years ago - By: Benzinga - Mentions: NRBO DOCN AAON ADAP ...

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday

3 years ago - By: Benzinga - Mentions: AAON MAPS FA AKYA ...

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session

3 years ago - By: Avalon GloboCare Corp.

Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 Million

3 years ago - By: Avalon GloboCare Corp.

Avalon GloboCare Receives Allowance for Joint U.S. Patent

3 years ago - By: Avalon GloboCare Corp.

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

3 years ago - By: InvestorPlace - Mentions: REVB JAKK TYDE ATHX ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

3 years ago - By: Avalon GloboCare Corp.

Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer

3 years ago - By: Avalon GloboCare Corp.

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

3 years ago - By: Viz Release

News Image

NASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities and Cellular Therapy Developers; Avalon Globocare Corp. (NASDAQ: AVCO)

4 years ago - By: Viz Release

News Image

NASDAQ Roundtable: $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies and Therapeutics be next? Avalon Globocare Corp. (NASDAQ: AVCO)

4 years ago - By: Viz Release

News Image

Cell-based Technologies and Therapeutics Global Developer Expands its Immuno-Oncology (mRNA)-based Platform. IND Application on the Horizon for this rising NASDAQ Company: Avalon Globocare Corp (NASDAQ: AVCO)

4 years ago - By: Viz Release

News Image

Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.

4 years ago - By: Avalon GloboCare Corp.

Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies

4 years ago - By: Viz Release

News Image

Leading global developer of cell-based technologies and therapeutics Expands its Cellular Immuno-Oncology Platform. NASDAQ Company Avalon Globocare Corp (NASDAQ: AVCO) could be the next big Biotech.

4 years ago - By: Viz Release

News Image

Avalon Globocare Corps (NASDAQ: AVCO) Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients. AVCO could be the next big Biotech

4 years ago - By: Viz Release

News Image

NASDAQ Company offers Life Saving Medical Advances; AI and Immunotherapy for Cancer and Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)